Anders Bengtsson Anaphylatoxin AB

Active
556692-5201Limited company (AB)Registered 2005KUNGSBACKA

Key figures

0 kr−100,0%
Revenue 2025
00,30,50,81201920202021202320242025

Key figures

2025

Summary: Anders Bengtsson Anaphylatoxin AB

What kind of company is it?

Anders Bengtsson Anaphylatoxin AB (org. no. 556692-5201) is a limited company (AB). The company was registered in 2005 and has existed for 20 years. Registered seat: Kungsbacka.

How is the company doing financially?

The company had no net sales in financial year 2025. The company was profitable in 1 of the 6 reported financial years. According to the annual report, the company had no employees in financial year 2025. At the end of financial year 2025, total assets were 1 351 322 kr and equity 1 128 868 kr (equity ratio 83,5 %). The annual report for 2025 proposes a dividend of 322 400 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 322 400 kr.

History
2025322 400 kr
2024211 000 kr
Summary of annual reports2019–2025
20202021202320242025
Sales revenue00010
Profit for the reporting year−11 745−22 500−516469 6750
Retained earnings of previous periods—————
Total assets1 922 1941 496 4291 282 6461 351 3221 351 322
Total liabilities73 39436 129208 12811 454222 454
Total equity1 848 8001 460 3001 074 5181 339 8681 128 868
Employees——000
Proposed dividend———211 000322 400

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Similar companies